These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 27448298)
1. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells. Qiu W; Yang Z; Fan Y; Zheng Q Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298 [TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway. Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517 [TBL] [Abstract][Full Text] [Related]
3. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway. Zhao C; Mo L; Li C; Han S; Zhao W; Liu L Mol Cell Endocrinol; 2020 Sep; 515():110925. PubMed ID: 32619584 [TBL] [Abstract][Full Text] [Related]
4. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway. Zhou Z; Liu Y; Ma M; Chang L Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013 [TBL] [Abstract][Full Text] [Related]
5. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway. Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy. Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469 [TBL] [Abstract][Full Text] [Related]
7. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928 [TBL] [Abstract][Full Text] [Related]
8. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling. Wang X; Lu X; Geng Z; Yang G; Shi Y J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866 [TBL] [Abstract][Full Text] [Related]
9. MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3. Deng X; Wu B; Xiao K; Kang J; Xie J; Zhang X; Fan Y Cell Physiol Biochem; 2015; 35(1):71-82. PubMed ID: 25547151 [TBL] [Abstract][Full Text] [Related]
10. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling. Geng Q; Deng H; Fu J; Cui F Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034 [TBL] [Abstract][Full Text] [Related]
11. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma. Li JY; Han C; Zheng LL; Guo MZ Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318 [TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells. Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573 [TBL] [Abstract][Full Text] [Related]
14. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related]
15. PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration. Chiappetta G; Valentino T; Vitiello M; Pasquinelli R; Monaco M; Palma G; Sepe R; Luciano A; Pallante P; Palmieri D; Aiello C; Rea D; Losito SN; Arra C; Fusco A; Fedele M Oncotarget; 2015 Mar; 6(7):5310-23. PubMed ID: 25595894 [TBL] [Abstract][Full Text] [Related]
16. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3. Li R; Liu J; Li Q; Chen G; Yu X Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618 [TBL] [Abstract][Full Text] [Related]
17. ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma. Zhou Y; Lan J; Wang W; Shi Q; Lan Y; Cheng Z; Guan H J Mol Histol; 2013 Oct; 44(5):555-63. PubMed ID: 23504200 [TBL] [Abstract][Full Text] [Related]
18. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1. Ma S; Jia W; Ni S Biochem Biophys Res Commun; 2018 Feb; 497(1):181-186. PubMed ID: 29427661 [TBL] [Abstract][Full Text] [Related]
19. ZnRF3 Induces Apoptosis of Gastric Cancer Cells by Antagonizing Wnt and Hedgehog Signaling. Qin H; Cai A; Xi H; Yuan J; Chen L Cell Biochem Biophys; 2015 Nov; 73(2):361-367. PubMed ID: 27352324 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development. Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]